Literature DB >> 7435762

Lateral instability of the ankle and results when treated by the Evans procedure.

S Vainionpää, P Kirves, E Läike.   

Abstract

Between 1968 and 1976 81 ankles of 77 patients with lateral instability of the ankle joint were operated on in the Kotka Central Hospital. Sixty patients with 62 ankle surgeries had postoperative followup. The average follow-up time was 5.2 years and the mean age of the patients was 28.3 years. In addition to the interview during the postoperative examination, all patients had anteroposterior (AP) mortice, lateral AP stress, and sagittal stress x-ray films. In the clinical examination ankle joint mobility, stability, peroneal function, predisposition to swelling, and circumference of the calf were investigated. Of the 62 ankles the result was excellent or good in 54 (87%). satisfactory in 5 (8%), and poor in 2 cases (5%). Of the 16 athletes' 18 ankles treated the result was excellent or good in 16 and satisfactory in 2 cases. The Evans procedure prevented talar tilting and gave good stability in anteroposterior direction.

Entities:  

Mesh:

Year:  1980        PMID: 7435762     DOI: 10.1177/036354658000800610

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  3 in total

1.  Relationship between stress ankle radiographs and injured ligaments on MRI.

Authors:  Kyoung Min Lee; Chin Youb Chung; Soon-Sun Kwon; Myung Ki Chung; Sung Hun Won; Seung Yeol Lee; Moon Seok Park
Journal:  Skeletal Radiol       Date:  2013-08-17       Impact factor: 2.199

2.  Treatment of chronic lateral ankle instability: a modified Broström technique using three suture anchors.

Authors:  Xinning Li; Timothy J Lin; Brian D Busconi
Journal:  J Orthop Surg Res       Date:  2009-12-02       Impact factor: 2.359

3.  Lateral ankle instability in high-demand athletes: reconstruction with fibular periosteal flap.

Authors:  Francesco Benazzo; Giacomo Zanon; Matteo Marullo; Stefano Marco Paolo Rossi
Journal:  Int Orthop       Date:  2013-08-15       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.